Marginum

The company develops fluorescence-based tissue detection systems, specifically the HIVEN device, for use during oncological surgery. This technology enables quantitative monitoring of aspirate tissue to help surgeons identify cancerous cells and minimize damage to healthy tissue without interrupting surgical workflows. Their solutions are designed for surgical professionals and medical institutions performing cancer treatments.